AL amyloidosis requires frequent monitoring to assess hematologic response.Hematologic response is tracked with the same tools used in plasma celldyscrasias with serum free light chain assays, quantitative immunoglobulins, andserum/urine immunofixation. The gene discussed is TNFSF14; the disease is AL amyloidosis.